Molnunat
Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.
- Category
- Covid-19 Support
- Active ingredient
- Molnupiravir
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 200mg
Molnunat details
- Condition
- Covid-19
- Alternative names
- Lagevrio
- Therapeutic class
- Antiviral
- Pharmacological class
- Nucleoside Analogue
- Contraindications
- hypersensitivity to active ingredient
- Precautions and warnings
- not for use as post-exposure prophylaxis; complete full course of treatment
- Minor side effects
- diarrhoea; nausea
- Moderate side effects
- dizziness
- Serious side effects
- anaphylaxis, requires immediate medical attention
- Dosage forms
- Capsule, hard
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Natco Pharma
- Onset Time
- 1–2 days
- Duration
- 5 days
- Storage instructions
- Store below 30°C.
- Age restrictions
- 18 years and older with risk factors.
- Pregnancy and breastfeeding
- Not recommended during pregnancy.
Patient summary
Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.
Mechanism of action
Molnupiravir is a prodrug that acts as a nucleoside analogue. When metabolized, it incorporates into the viral RNA during replication, causing a high mutation rate in the SARS-CoV-2 genome, which effectively inhibits viral progression.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Molnunat
Molnunat contains the active ingredient Molnupiravir and is used for the treatment of Covid-19. The same ingredient is also sold under the brand name Lagevrio. Manufactured by Natco Pharma, this product is supplied in bottles with a strength of 200mg.
Buying Molnunat online
Molnunat is registered across 13 markets including Taiwan, South Korea and Japan, with availability also in the UAE, Singapore and Hong Kong. Generic Molnupiravir, much of it made in India, is far more affordable than the original brand. This offers a practical solution for expats and other residents living far from a well stocked pharmacy who need to source medication online with direct delivery across these regions.